Whole genome sequencing of Plasmodium falciparum clinical isolates associated with ACT failure
This study includes the whole genome sequencing data from Plasmodium falciparum clinical isolates collected in France, associated with ACT failure (Dihydroartemisinin-piperaquine or Artemether-lumefantrine). The aim is to identify and track mutations in known drug resistant genes after antimalarial treatment to characterize their genetic diversity with potential to discover features that will help disease control.
This study includes the whole genome sequencing data from Plasmodium falciparum clinical isolates collected in France, associated with ACT failure (Dihydroartemisinin-piperaquine or Artemether-lumefantrine). The aim is to identify and track mutations in known drug resistant genes after antimalarial treatment to characterize their genetic diversity with potential to discover features that will help disease control.